Atom Investors LP Candel Therapeutics, Inc. Transaction History
Atom Investors LP
- $906 Million
- Q3 2024
A detailed history of Atom Investors LP transactions in Candel Therapeutics, Inc. stock. As of the latest transaction made, Atom Investors LP holds 14,873 shares of CADL stock, worth $113,480. This represents 0.01% of its overall portfolio holdings.
Number of Shares
14,873Holding current value
$113,480% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding CADL
# of Institutions
56Shares Held
6.44MCall Options Held
109KPut Options Held
130K-
Northpond Ventures, LLC1.94MShares$14.8 Million48.35% of portfolio
-
Vanguard Group Inc Valley Forge, PA946KShares$7.22 Million0.0% of portfolio
-
Black Rock Inc. New York, NY823KShares$6.28 Million0.0% of portfolio
-
State Street Corp Boston, MA492KShares$3.75 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA449KShares$3.43 Million0.0% of portfolio
About Candel Therapeutics, Inc.
- Ticker CADL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,891,900
- Market Cap $220M
- Description
- Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the...